[{"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-1046-2015", "product_description": "Renacidin Irrigation Solution, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"country": "United States", "city": "Columbus", "address_1": "1809 Wilson Rd", "reason_for_recall": "Failed Stability Specifications: Out of specification result for preservative sodium benzoate.", "address_2": "", "product_quantity": "2,149 Bottles", "code_info": "Lot #: 360241A, Expiry: 05/2015.", "center_classification_date": "20140728", "distribution_pattern": "U.S. Nationwide", "state": "OH", "product_description": "OXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only.  Boehringer Ingelheim, Roxane Laboratories. Roxane Laboratories, Inc. Columbus, Ohio 43216. NDC: 0054-0523-41.", "report_date": "20140806", "classification": "Class III", "openfda": {}, "recalling_firm": "Boehringer Ingelheim Roxane Inc", "recall_number": "D-1486-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68879", "termination_date": "20150529", "more_code_info": "", "recall_initiation_date": "20140728", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-246-2014", "product_description": "Mitomycin 20mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "102 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Cary", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M016"], "brand_name": ["COMFORT SHIELD BARRIER"], "generic_name": ["DIMETHICONE"], "manufacturer_name": ["Sage Products LLC"], "product_ndc": ["53462-915"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["DIMETHICONE"], "rxcui": ["968663", "1088604"], "spl_id": ["419e18cd-fa52-b78d-e063-6294a90a467c"], "spl_set_id": ["cc08f571-84ae-4c2f-b09d-a83a8efc39f5"], "package_ndc": ["53462-915-50", "53462-915-51", "53462-915-62", "53462-915-80", "53462-915-81", "53462-915-24", "53462-0915-62"], "is_original_packager": [true], "nui": ["N0000010282"], "pharm_class_pe": ["Skin Barrier Activity [PE]"], "unii": ["92RU3N3Y1O"]}, "product_type": "Drugs", "event_id": "74819", "recalling_firm": "Sage Products LLC", "address_1": "3909 3 Oaks Rd", "address_2": "N/A", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, United Arab Emirates, Australia, Bahrain, Canada, Germany, Denmark, UK, Honduras, Ireland, Mexico, Malaysia, Netherlands, Portugal, Saudi Arabia, Singapore, and El Salvador.", "recall_number": "D-0229-2017", "product_description": "COMFORT SHIELD (dimethicone) Barrier Cream Cloths, 3%, packaged as impregnated cloths wrapped in flexible packaging, further packed into inner cartons, with the inner cartons are placed into an over shipper sold in a) 3-count disposable barrier cloths per package, 45 packages per carton, 2 cartons (90 packages) per case, Reorder # 7503, NDC 53462-915-50; b) 8-count disposable barrier cloths per package, 24 packages per carton, 2 cartons (48 packages) per case, Reorder # 7905, NDC 53462-915-80;   c)  24-count disposable barrier cloths per package, 9 packages per carton, 2 cartons (18 packages) per case, Reorder # 7526, NDC 53462-0915-62; Sage Products LLC, 3909 Three Oaks Road, Cary, Illinois 60013.", "product_quantity": "576,802 cases total for product codes 7503, 7905, and 7526", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: contamination with the bacteria, Burkholderia cepacia.", "recall_initiation_date": "20160729", "center_classification_date": "20161222", "termination_date": "20190311", "report_date": "20161228", "code_info": "Lot #: a) 53957, Exp 03/06/18; b) 54769, Exp 04/22/18; 54922, Exp 05/03/18; 55781, Exp 06/19/18; c) 53095, Exp 07/13/17"}, {"status": "Ongoing", "city": "North Miami Beach", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "72058", "recalling_firm": "The One Minute Miracle Inc", "address_1": "3322 NE 166th St", "address_2": "N/A", "postal_code": "33160-3844", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0230-2016", "product_description": "MIRACLE DIET 30 capsules, 30-count bottle, Manufactured Exclusively For: The One Minute Miracle Inc., UPC 7 538073516768.", "product_quantity": "1 bottle", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Miracle Diet 30 was found to contain undeclared phenolphthalein, a drug product once contained in over-the-counter laxatives but was taken off the U.S. market due to safety concerns, making this product an unapproved drug.", "recall_initiation_date": "20150827", "center_classification_date": "20151112", "report_date": "20151118", "code_info": "All lots through Expiration Date 04/15/2018"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "98 pellets", "code_info": "All lots distributed between November 2014 and May 2015;  01122015@36, 7/11/2015; 04022015@40, 9/29/2015; 05072015@56, 11/3/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Estradiol 100 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1465-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "65172", "recalling_firm": "King Legacy, a wholly owned subsidiary of Pfizer", "address_1": "501 5th Street", "address_2": "N/A", "postal_code": "37620-2304", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-421-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b) 1000-count bottles (NDC 60793-850-10), Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620", "product_quantity": "51,591 bottles", "reason_for_recall": "Subpotent Drug: The products were below specification for potency at the expiry stability point.", "recall_initiation_date": "20130430", "center_classification_date": "20130520", "termination_date": "20160630", "report_date": "20130529", "code_info": "Lot # a) 65228, Exp. 06/13; 65636, Exp. 08/13; b) 65180, Exp. 05/13; 65769, Exp. 07/13"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:    0402610    0406777    0407425    0407640", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "FORSKOLIN/PAPAVARINE/PHENTOLAMINE 200MCG/40MG/3MG/ML INJECTABLE 5 ML; FORSKOLIN/PAPAVARINE/PHENTOLAMINE/ALPROSTADIL 100MCG/30MG/1MG/30MCG/ML INJECTABL 10 ML; (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1523-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0028-2024", "product_description": "HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2010-2", "product_quantity": "1,190 50 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot:17-275728, Exp. 10/9/2023; 17-275791, 17-275803, Exp. 10/10/2023; 17-276244, Exp. 10/20/2023."}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079031"], "brand_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-5346", "0093-5347", "0093-5348"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "rxcui": ["1806177", "1806179", "1806183"], "spl_id": ["663ba889-95b5-45c2-af06-c90459d30d6d"], "spl_set_id": ["034fb7cd-e183-475e-8beb-64fd88facc8f"], "package_ndc": ["0093-5346-01", "0093-5347-01", "0093-5348-01"], "is_original_packager": [true], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "65515", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-849-2013", "product_description": "Methylphenidate Hydrochloride Extended-Release Capsules (LA), 40 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS USA, NDC 0093-5348-01", "product_quantity": "7,579 bottles", "reason_for_recall": "Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.", "recall_initiation_date": "20130618", "center_classification_date": "20130807", "termination_date": "20140827", "report_date": "20130814", "code_info": "34010287A, 34010288A, 34010289A, exp 4/2014; 34011513A, 34011514A, and 34011515A, exp 06/14."}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76407", "recalling_firm": "Cherry Hill Sales Co.", "address_1": "1115 Eden Way N", "address_2": "N/A", "postal_code": "23320-2751", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Michigan, Illinois, New York, Florida, Pennsylvania .", "recall_number": "D-0486-2017", "product_description": "MakeSense PHARMA ANTIFUNGAL CREAM 1 oz. Miconazole Nitrate 2%, 1 oz. (28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-208-28", "product_quantity": "2,400 cartons", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20170127", "center_classification_date": "20170218", "termination_date": "20170419", "report_date": "20170301", "code_info": "Lot #103810; Exp. 09/17  Lot #105303; Exp. 04/18  NDC 69020-208-28  UPC 857181005092"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0900-2022", "product_description": "SB-5 Papaverine 30 mg/mL Phentolamine 3 mg/mL PGE 50 mcg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0024-10", "product_quantity": "75 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lot: B24D02-22 BUD: 02/02/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "93960", "recalling_firm": "Stason Pharmaceuticals, Inc.", "address_1": "11 Morgan", "address_2": "", "postal_code": "92618-2005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0367-2024", "product_description": "Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com", "product_quantity": "54, 131 bottles", "reason_for_recall": "Failed Dissolution Specifications: results slightly under spec at at 9-months.", "recall_initiation_date": "20240209", "center_classification_date": "20240306", "report_date": "20240313", "code_info": "Lot #: a)22K012, 22K013A, Exp: 04/30/2024; 23A001, 23A002A, Exp: 07/31/2024; 23D006, 23D007A, 23D007C, Exp:10/31/2024; b)22K013B, Exp: 04/30/2024; 23A002B, Exp:07/31/2024; 23D007B, Exp: 10/31/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077259"], "brand_name": ["TIMOLOL MALEATE"], "generic_name": ["TIMOLOL MALEATE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["64980-513", "64980-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL MALEATE"], "rxcui": ["1923428", "1992303"], "spl_id": ["7ef88352-6fe4-48a4-b72b-15419d3ed051"], "spl_set_id": ["2ed21930-1e05-46de-8acd-cb6f4798a7fa"], "package_ndc": ["64980-513-05", "64980-513-01", "64980-513-15", "64980-514-05", "64980-514-01", "64980-514-15"], "is_original_packager": [true], "upc": ["0364980513050", "0364980514057"], "unii": ["P8Y54F701R"]}, "product_type": "Drugs", "event_id": "97219", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S Nationwide.", "recall_number": "D-0543-2025", "product_description": "Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-05.", "product_quantity": "154,176 bottles", "reason_for_recall": "Defective Container: spike of the cap becomes lodged in the nozzle of the product bottle.", "recall_initiation_date": "20250705", "center_classification_date": "20250729", "report_date": "20250806", "code_info": "Lot#: 083L061, Exp.: 11/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0475-2019", "product_description": "Pyridoxine HCl, 100 mg/mL Injection, 10ml vial, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "8 10ml vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lot: 10302018@3 BUD: 12/14/2018"}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90599", "recalling_firm": "Vi-Jon, LLC", "address_1": "1 Swan Dr", "address_2": "", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA as well as Canada and Panama.", "recall_number": "D-1513-2022", "product_description": "Magnesium Citrate SALINE LAXATIVE, Oral Solution, 1.745 g, Grape Flavor, 10 FL OZ (296 mL),  a)\tBest Choice UPC 0 70038 66220 4 Proudly Distributed By: Valu Merchandisers, Co. 5000 Kansas Ave Kansas City, KS 66106;  b)\tCVS Health UPC 0 50428 30745 8 Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895, CVS Health UPC 0 50428 32503 2 Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895;  c)\tEquate NDC 49035-592-38 UPC 6 81131 28715 9 Distributed By: Walmart, Inc. Bentonville, AR 72716;  d)\tHEB UPC 0 41220 51088 7 Made With Pride & Care For H-E-B San Antonio, TX 78204; Kroger UPC 0 41260 00871 9 Distributed By The Kroger Co. Cincinnati, Ohio 45202;  e)\tLeader NDC 70000-0576-1 UPC 0 96295 14105 4 Distributed By Cardinal Health Dublin, Ohio 43017;  f)\tRexall UPC 0 72785 13417 1 Distributed By Dolgencorp, LLC 100 Mission Ridge Goodlettsville, TN 37072 USA, Rexall UPC 0 72785 13417 1 Distributed By Old East Main Co. 100 Mission Ridge Goodlettsville, TN 37072;  g)\tWalgreens NDC 0363-7162-38 UPC 3 11917 20159 7 Distributed By: Walgreen Co., 200 Wilmot RD., Deerfield, IL 60015 (purple label), Walgreens NDC 0363-7162-38 UPC 3 11917 20159 7 Distributed By: Walgreen Co. 200 Wilmot RD., Deerfield, IL 60015 (blue label)", "product_quantity": "8,064,834", "reason_for_recall": "CGMP Deviations;", "recall_initiation_date": "20220715", "center_classification_date": "20220909", "termination_date": "20240509", "report_date": "20220921", "code_info": "All lots remaining within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Xiamen", "state": "N/A", "country": "China", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "91410", "recalling_firm": "GFA Production Xiamen Co. Ltd.", "address_1": "Huli Industrial Park No. 20", "address_2": "Meixi Road; Tong'An", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Canada.", "recall_number": "D-0249-2023", "product_description": "Easy Care First Aid 10 Person 2009 ANSI, First Aid Kit, containing Easy Care first aid After Burn Cream 0.9 g packets, Product # 9999-2128", "product_quantity": "194460 packets", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.", "recall_initiation_date": "20221223", "center_classification_date": "20230127", "termination_date": "20250729", "report_date": "20230208", "code_info": "Lot #: W05L28, exp 12/28/2023; W06F10, exp 06/10/2024; W06H15, exp 08/15/2024."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1392-2016", "product_description": "2 mcg/mL Fentanyl Citrate and 0.075% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; 130 mL in 150 mL Baxter Intravia Bag, Service Code, 2K9226 (NDC 61553-226-98), 200 mL in 250 mL Baxter Intravia Bag, Service Code 2K9294 (NDC 61553-0294-92), Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141", "product_quantity": "950 bags", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Service Code 2K9226 , Lot Number 160450145M , Exp. Date 5/9/2016 ;  Service Code 2K9226 , Lot Number 160530166M , Exp. Date 5/17/2016 ;  Service Code 2K9226 , Lot Number 160560080M , Exp. Date 5/19/2016 ;  Service Code 2K9226 , Lot Number 160670164M , Exp. Date 5/31/2016 ;  Service Code 2K9226 , Lot Number 160730130M , Exp. Date 6/6/2016 ;  Service Code 2K9226 , Lot Number 160770032M , Exp. Date 6/10/2016 ;  Service Code 2K9226 , Lot Number 160810035M , Exp. Date 6/13/2016 ;  Service Code 2K9226 , Lot Number 160820135M , Exp. Date 6/15/2016 ;  Service Code 2K9226 , Lot Number 160870152M , Exp. Date 6/20/2016 ;  Service Code 2K9226 , Lot Number 160890036M , Exp. Date 6/22/2016 ;  Service Code 2K9226 , Lot Number 160950040M , Exp. Date 6/27/2016 ;  Service Code 2K9294 , Lot Number 160400210M , Exp. Date 5/10/2016 ;  Service Code 2K9294 , Lot Number 160700164M , Exp. Date 6/9/2016 ;", "more_code_info": ""}, {"status": "Terminated", "city": "San Nicolas De Los Georgia", "state": "N/A", "country": "Mexico", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86078", "recalling_firm": "Liq-E S.A. De C.V.", "address_1": "Puerto Tampico 345", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the United States and Mexico.", "recall_number": "D-0254-2021", "product_description": "OPTIMUS LUBRICANTS Instant Hand Sanitizer, (alcohol 70% v/v) 55 Gal (208 L) drum, Made in Mexico, Liq-E, S.A. DE C.V., Puerto Tampico No. 345 Col.. La Fe San Nicolas de Los Garza, Nuevo Leon, Mexico. C.P. 66477.UPC # 7 501799 118998", "product_quantity": "575 drums", "reason_for_recall": "Chemical Contamination: Products contain methanol and were below the label claim for ethanol content", "recall_initiation_date": "20200720", "center_classification_date": "20210212", "termination_date": "20240408", "report_date": "20210224", "code_info": "Lot #  L-1160, L-2160, L-3160, L-1180, L-2180, L-2190, Exp. 05/2022; L-1200, L-2200, L-3200, L-4200, L-5200, L-1210 and L-2210, Exp. date 06/2022"}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-066"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "rxcui": ["579907"], "spl_id": ["130364f2-4379-9324-e063-6294a90a9747"], "spl_set_id": ["b469f1c4-bd94-6f50-e053-2995a90a452f"], "package_ndc": ["50268-066-15"], "is_original_packager": [true], "unii": ["K679OBS311"]}, "product_type": "Drugs", "event_id": "96741", "recalling_firm": "BRS Analytical Services, LLC", "address_1": "11697 Lakeside Crossing Ct", "address_2": "N/A", "postal_code": "63146-8606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0405-2025", "product_description": "Carboxymethylcellulose Sodium Ophthalmic Gel 1%, Carboxymethlycellulose Sodium 1% Eye Lubricant, Lubricant Eye Gel, Soothing Gel, Sterile, 0.5 FL OZ (15mL) per bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-066-15.", "product_quantity": "1,610 cases (24 cartons per case)", "reason_for_recall": "cGMP deviations and lack of assurance of sterility.", "recall_initiation_date": "20250423", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot, expiry:  Lot 114, exp 9/04/25; Lot 115, exp 9/06/25; Lot 116, exp 9/10/25; Lot 207, exp 12/05/26", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0953-2019", "product_description": "NET Remedies #3 Water Homeopathic Preparation, Oral Liquid, 57 mL, NDC 57955-4203-2", "product_quantity": "15898 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: NR-031516L Exp. 03/19; NR-010617C Exp. 01/20; NR-011216K Exp. 01/19; NR-050916F Exp. 05/19; NR-051917A Exp. 05/20; NR-061616B Exp. 06/19; NR-080116F Exp. 08/19; NR-090115A Exp. 09/18; NR-090616C Exp. 09/19; NR-101416C Exp. 10/19; NR-120815N Exp. 12/18; NR-020118C Exp. 02/20; NR-022318C Exp. 02/20; NR-051618A Exp. 05/20; NR-071718K Exp. 07/20; NR-081017C Exp. 08/19; NR-101017C Exp. 10/19; NR-120317C Exp. 12/19"}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205063"], "brand_name": ["ISOTRETINOIN"], "generic_name": ["ISOTRETINOIN"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-2433", "0591-2434", "0591-2451", "0591-2435", "0591-2501", "0591-2436"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ISOTRETINOIN"], "rxcui": ["197843", "197844", "197845", "403930", "1547561", "1547565"], "spl_id": ["2f164fd8-4912-4149-9292-0dc2249a69a3"], "spl_set_id": ["1cf11710-f966-4529-8e08-02175f588bca"], "package_ndc": ["0591-2433-45", "0591-2433-15", "0591-2434-45", "0591-2434-15", "0591-2451-45", "0591-2451-15", "0591-2435-45", "0591-2435-15", "0591-2501-45", "0591-2501-15", "0591-2436-45", "0591-2436-15"], "is_original_packager": [true], "nui": ["N0000175607", "M0018962"], "pharm_class_epc": ["Retinoid [EPC]"], "pharm_class_cs": ["Retinoids [CS]"], "unii": ["EH28UP18IF"]}, "product_type": "Drugs", "event_id": "94294", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0439-2024", "product_description": "Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only,  Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054.  Blister Pack NDC 0591-2436-45, Carton NDC 0591-2436-15", "product_quantity": "5,304 3x10-cartons", "reason_for_recall": "Superpotent Drug: The 3-month stability result for assay was found to be above specification limit", "recall_initiation_date": "20240328", "center_classification_date": "20240408", "report_date": "20240417", "code_info": "Lot #: 100044259, Exp 06/30/2025."}, {"status": "Terminated", "city": "Roseburg", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81883", "recalling_firm": "Hiers Enterprises, LLC dba Northwest Compounding Pharmacy", "address_1": "1350 Ne Stephens St Ste 42", "address_2": "N/A", "postal_code": "97470-6410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients.    These are compounded products - labels vary for each compound - specific to each patient.  Firm did not provide labeling.", "recall_number": "D-0395-2019", "product_description": "HCG liquid, 1000u/ml, RX, glass vial, various", "product_quantity": "30 ml", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190102", "center_classification_date": "20190127", "termination_date": "20230328", "report_date": "20190109", "code_info": "10162018@22"}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209042"], "brand_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "generic_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-499", "67877-500", "67877-501", "67877-502"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "OLMESARTAN MEDOXOMIL"], "rxcui": ["730861", "730866", "730869", "730872"], "spl_id": ["32238052-6c4c-4b29-a59e-524c819c69f1"], "spl_set_id": ["c1204fbe-d086-43cf-bbaa-efec9cd0487c"], "package_ndc": ["67877-499-30", "67877-499-90", "67877-500-30", "67877-500-90", "67877-501-30", "67877-501-90", "67877-502-30", "67877-502-90"], "is_original_packager": [true], "unii": ["6M97XTV3HD", "864V2Q084H"]}, "product_type": "Drugs", "event_id": "97293", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "N/A", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0576-2025", "product_description": "Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-501-30", "product_quantity": "8,568 bottles", "reason_for_recall": "Failed Dissolution Specifications: low dissolution results", "recall_initiation_date": "20250721", "center_classification_date": "20250808", "report_date": "20250820", "code_info": "Lot 23121560, Exp 4/30/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-609-2015", "product_description": "Dacarbazine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "50 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91921", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0484-2023", "product_description": "Simvastatin, USP, 10 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0688-30 b) 90-count bottle, NDC61919-0688-90, Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534", "product_quantity": "30 count: 6 bottles; 90 count: 106 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230313", "center_classification_date": "20230324", "termination_date": "20240617", "report_date": "20230405", "code_info": "a) [30-count bottles] Lot, expiry: 05AU2206, exp 10/31/23;  b) [90-count bottles] Lot, expiry: 30MA2213, exp 6/30/23; 10DE2124, exp 3/31/23; 15MA2224, exp 5/32/23; 27JA2229, exp 3/31/23."}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "B5021 Exp 9/30/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Metabolase Forte Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-753-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83908", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to major distributors throughout the United States who may have further distributed the product.", "recall_number": "D-0183-2020", "product_description": "Ranitidine Tablets, USP 75 mg, a.) 30- count bottles (NDC 0363-0131-30), b.) 80-count bottles (NDC 0363-0131-80)  (Walgreens) OTC", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191001", "center_classification_date": "20191105", "report_date": "20191113", "code_info": "Batch Numbers:  All lots within expiry."}, {"status": "Terminated", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90813", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-1496-2022", "product_description": "Sodium Chloride Ophthalmic Ointment USP, 5%, Sterile, Net Wt 3.5 g (1/8 oz) tube, Mfg by: Akorn, Inc., Lake Forest , IL 600405, NDC 17478-622-35", "product_quantity": "48,636 tubes", "reason_for_recall": "cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.", "recall_initiation_date": "20220831", "center_classification_date": "20220906", "termination_date": "20240618", "report_date": "20220914", "code_info": "Lot#: 9J58A, 9J58B,  Exp 8/31/2022"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0470-2022", "product_description": "Legatrin PM Pain Reliever/Sleep Aid (acetaminophen 500 mg, diphenhydramine HCl 50mg caplets) 50-count bottles, Manufactured for: Church & Dwight Co., Inc. Ewing, NJ 08628 NDC 10237-907-50", "product_quantity": "174,852 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: HY9042, Exp. Date 02/2022; HY9094, HY9112, Exp. Date 04/2022; HY9134, Exp. Date 05/2022; HY9267, Exp. Date 09/2022"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "74746", "recalling_firm": "Clinique International", "address_1": "767 5th Ave", "address_2": "N/A", "postal_code": "10153-0023", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1477-2016", "product_description": "CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15, 1 FL. OZ.LIQ./30 ml bottle within a carton, Clinique Labs., Dist. New York, N.Y., 10022; New York, London W1K 3BQ; Paris, UPC No. 20714-48240-4, Shade 05 (D-G)", "product_quantity": "1,771,244 bottles for all shades", "reason_for_recall": "Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay.", "recall_initiation_date": "20160517", "center_classification_date": "20160826", "termination_date": "20180614", "report_date": "20160907", "code_info": "all lots"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-600-2015", "product_description": "Cortisone Acetate Micronized active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Completed", "city": "Florham Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86805", "recalling_firm": "BASF Corporation", "address_1": "100 Park Ave", "address_2": "N/A", "postal_code": "07932-1049", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "USA Nationwide and Worldwide", "recall_number": "D-0149-2021", "product_description": "Kollidon CL-M Crospovidone Ph.Eur.Type B, USP/NF, JP, micronized, packaged in 30 kg plastic drums, Manufacturer: BASF SE, Carl-Bosch-Strabe 38, 67056 Ludwigshafen, Germany, Co-Manufactured by Siegfried PharmaChemikalien Minden GmbH, D-32423 Minden", "product_quantity": "4560 kg", "reason_for_recall": "Cross contamination: the excipient was found to be contaminated with theophylline.", "recall_initiation_date": "20201117", "center_classification_date": "20201215", "report_date": "20201223", "code_info": "Batch # 18472036, 18472041."}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave", "reason_for_recall": "Subpotent", "address_2": "Suite A", "product_quantity": "1536 cartons", "code_info": "The following product was affected:   AHP Lot #: 130007  Expiration Date: 01/31/2014  Carton NDC #: 68084-633-01  Single Dose NDC #: 68084-633-11", "center_classification_date": "20131205", "distribution_pattern": "Nationwide", "state": "OH", "product_description": "Valacyclovir HCl Tablets, 500 mg, 100 tablets (10x10) blister cards, Rx only, Packaged and Distributed by: American Health Packaging, Columbus, OH  NDC 68084-633-01", "report_date": "20131211", "classification": "Class II", "openfda": {}, "recalling_firm": "American Health Packaging", "recall_number": "D-323-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66451", "termination_date": "20150626", "recall_initiation_date": "20130802", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0228-2015", "product_description": "VITAMIN B COMPLEX (PRES) injectable, 100mg, 10 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070.", "product_quantity": "490 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140811@5, discard date 10/16/2014  Lot #: 20140827@12, discard date 11/25/2014"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "633 Cases", "code_info": "Product Code: 6974; Lots: 58322, 58649, EXP 04/03/2018; 60186, EXP 08/02/2018; 60747, EXP 09/06/2018.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Q Care RX Petite Oral Cleansing & Suctioning System with 0.12% Chlorhexidine Gluconate (CHG) Oral Rinse. Contains 1 Covered Yankauer and Y-Connector, 2 Untreated Petite Suction Toothbrush packages,  2 Single dose bottles of 0.12% CHG Oral Rinse, 4 Petite Suction Oral Swab packages with Corinz Antiseptic Cleansing and Moisturizing Oral Rinse, 2 Oropharyngeal Suction Catheter packages. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6974 UPC 6 18029 83097 5", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0406-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Baudette", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89556", "recalling_firm": "ANI Pharmaceuticals, Inc.", "address_1": "210 W Main St", "address_2": "N/A", "postal_code": "56623-2467", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0564-2022", "product_description": "Alprazolam Tablets, USP 0.25 mg, packaged in a) 100-count bottles (NDC 67253-900-10), b) 500-count bottles (NDC 67253-900-50), and c) 1000-count bottles (NDC 67253-900-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977", "product_quantity": "73,920 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20220215", "center_classification_date": "20220217", "termination_date": "20221025", "report_date": "20220223", "code_info": "Lot #: a) 19C003A, Exp. Date 03/2022; 19G002A, exp. date 07/2022; b) 19C004B, Exp. Date 03/2022; c) 19C048C, Exp. Date 03/2022"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0917-2019", "product_description": "NET Remedies #24 Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia", "product_quantity": "1200 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: AUS-011916P Exp. 01/19; AUS-030816M Exp. 03/19; AUS-061016D Exp. 06/19; AUS-081516A Exp. 08/19"}, {"status": "Completed", "city": "Ridgeland", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90798", "recalling_firm": "Carolina Infusion", "address_1": "95 Bees Creek Rd", "address_2": "", "postal_code": "29936-7540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1528-2022", "product_description": "TRI-MIX 30/1/40 Injectable, 10 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220826", "center_classification_date": "20220915", "report_date": "20220921", "code_info": "Lots: 07052022@8, BUD: 09/03/2022; 07292022@10, BUD: 09/27/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65154", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.", "recall_number": "D-445-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 100 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1323-01", "product_quantity": "142,103 Bottles", "reason_for_recall": "cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.", "recall_initiation_date": "20130401", "center_classification_date": "20130521", "termination_date": "20140508", "report_date": "20130529", "code_info": "Lot #: 1095184, 1095185, 1095186, 1095187, Exp Apr-13; 1096370, Exp May-13; 1097547, 1097588, 1097589, Exp Jul-13."}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0062-2020", "product_description": "Hydroxocobalamin 10 mg/20 mL (0.5 mg/mL) 20 mL fill in a 30 mL Vial, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678337", "product_quantity": "345 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0172-2018", "product_description": "Estriol 0.1% (1 mg/gm) Cream packaged in jars, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "300 jars", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 07182017@45 BUD: 1/14/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090583"], "brand_name": ["AMPICILLIN"], "generic_name": ["AMPICILLIN SODIUM"], "manufacturer_name": ["Xellia Pharmaceuticals USA LLC"], "product_ndc": ["70594-084", "70594-085", "70594-086", "70594-087"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["AMPICILLIN SODIUM"], "rxcui": ["1721473", "1721474", "1721475", "1721476"], "spl_id": ["03c0f1f1-0132-46ee-a71c-f5e77bd6131e"], "spl_set_id": ["94421dac-7865-49f8-ae52-871eee6465ac"], "package_ndc": ["70594-084-01", "70594-084-02", "70594-085-01", "70594-085-02", "70594-086-01", "70594-086-02", "70594-087-01", "70594-087-02"], "is_original_packager": [true], "unii": ["JFN36L5S8K"]}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0586-2023", "product_description": "Ampicillin for Injection, USP 500 mg per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-085-02", "product_quantity": "59,530 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"country": "United States", "city": "Earth City", "address_1": "13600 Shoreline Dr", "reason_for_recall": "Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.", "address_2": "", "product_quantity": "111,384 sample packs", "code_info": "Lot  1112467 Exp. 02/15", "center_classification_date": "20140204", "distribution_pattern": "Nationwide and Puerto Rico.", "state": "MO", "product_description": "Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only,  Forest Pharmaceuticals Inc., St. Louis, MO 63045  NDC 0456-3428-05.", "report_date": "20140212", "classification": "Class III", "openfda": {}, "recalling_firm": "Forest Pharmaceuticals Inc", "recall_number": "D-1065-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66838", "termination_date": "20140507", "more_code_info": "", "recall_initiation_date": "20131113", "postal_code": "63045", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "City of Industry", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64929", "recalling_firm": "Total Resources Intl", "address_1": "420 S Lemon Ave Ste A", "address_2": "", "postal_code": "91789-2956", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-890-2013", "product_description": "Medi-First Brand First Aid Kit, MEDI-FIRST 61 Piece Kit, Home, Workplace Travel, Sport, Total Resources International, Walnut, CA 91789", "product_quantity": "", "reason_for_recall": "CGMP Deviations: The first aid kits that are subject to the voluntary recall is being initiated due to failure in stability testing of the active ingredient Benzalkonium Chloride.", "recall_initiation_date": "20130409", "center_classification_date": "20130813", "termination_date": "20140107", "report_date": "20130821", "code_info": "Lot  11214-07", "more_code_info": ""}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0297-2018", "product_description": "Medline Irrigation W/Piston SYR Tray, Sterile, Single Use Only. Packaged in Mexico for Medline Industries, Inc., Northfield, IL 60093", "product_quantity": "2,336 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDT1094 and DYNDT1094H", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0186-2018", "product_description": "Oxytocin 30 Units in 0.9% Sodium Chloride Solution (PF) IV Bag, For IV Infusion Use, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "963 bags", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lots: 10112017@10 BUD: 1/9/2018; 10252017@9 BUD: 1/23/2018", "more_code_info": ""}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.", "address_2": "", "product_quantity": "868,104 cartons", "code_info": "Lot #: 10089568, Exp 5/31/2013; 10093324, 10094745, 10097626, 10097627, Exp 7/31/2013; 10098588, Exp 9/30/2013.    NeoCitran Extra Strength Total 7 Symptom Relief Plus Mucous Relief : 10093316, Exp 7/31/2013; 10098591, Exp 9/30/2013; 10101027, Exp 10/31/2013; 10102623, Exp 11/30/2013; 10106813, Exp 1/31/2014; 10115844, Exp 6/30/2014; 10124363, Exp 9/30/2014.", "center_classification_date": "20140117", "distribution_pattern": "Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.", "state": "NE", "product_description": "Theraflu MAX-D Severe  Cold & Flu (acetaminophen 1000 mg, dextromethorphan HBr 30 mg, guaifenesin 400 mg, pseudoephedrine HCl 60 mg) powder packets, Natural Citrus flavor, 6-count packets per carton,  Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ  07054-0622, NDC 0067-6427-06, UPC 3 0067-6427-06 5.    Also packaged under foreign label: NeoCitran Extra Strength Total 7 Symptom Relief Plus Mucous Relief powder packets, Soothing Lemon flavor, 10-count single dose pouches per carton, Novartis Consumer Health Canada, Inc., Mississauga, ON, UPC 0 58478 10701 1.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-753-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65490", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130618", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Shenandoah", "address_1": "604 W Thomas Ave", "reason_for_recall": "Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.", "address_2": "Po Box 130", "product_quantity": "1,924,297 bulk tablets", "code_info": "Lot HB06311", "center_classification_date": "20120622", "distribution_pattern": "Nationwide and PR.", "state": "IA", "product_description": "Thyro-Tab 0.050mg., packaged in bulk drums for repackaging.  The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "report_date": "20120704", "classification": "Class II", "openfda": {}, "recalling_firm": "Lloyd Inc", "recall_number": "D-1392-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "61094", "termination_date": "20130730", "more_code_info": "", "recall_initiation_date": "20120203", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88884", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0259-2022", "product_description": "Diclofenac Sodium Topical Solution USP, 1.5 w/w, 5 fl oz (150 mL) plastic bottles, Rx only, Teligent Pharma, Inc., Buena, New Jersey, 08310, NDC 70512-025-05.", "product_quantity": "5400 units", "reason_for_recall": "Defective Container", "recall_initiation_date": "20211019", "center_classification_date": "20211123", "termination_date": "20240618", "report_date": "20211201", "code_info": "Lot #: 15028, Exp 1/2023; 15379, Exp 3/2023.", "more_code_info": ""}, {"status": "Terminated", "city": "Huntsville", "state": "AL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "70168", "recalling_firm": "Qualitest Pharmaceuticals", "address_1": "120 Vintage Dr NE", "address_2": "N/A", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0331-2015", "product_description": "ACETAMINOPHEN and CODEINE PHOSPHATE ORAL SOLUTION USP, 120 mg/12 mg per 5 mL, packaged in a) 4 oz. (120 mL) bottles, NDC 0603-9013-54, UPC 3 0603-9013-54 8 and b) ONE PINT (473 mL) bottles, NDC 0603-9013-58, UPC 3 0603-9013-58 6, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL  35811", "product_quantity": "a) 3936 bottles; b) 84420 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: High out of specification results for the known impurity p-Aminophenol.", "recall_initiation_date": "20141222", "center_classification_date": "20150106", "termination_date": "20160201", "report_date": "20150114", "code_info": "Lot #: a) L140H13B, Exp. 03/15; L001D14A. Exp. 08/15; b) L140H13A, Exp. 03/15; L205K13A, Exp. 05/15; L019L13A, L020L13A, Exp. 06/15; L001D14B, 08/15; L091D14A, Exp. 10/15", "more_code_info": ""}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0484-2018", "product_description": "Diclofenac Sodium USP for prescription compounding, packaged in a) 25g (NDC 58597-8012-4); b)100g (NDC 58597-8012-6); c) 500 g (NDC 58597-8012-7); d) 1000g (NDC 58597-8012-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "116850 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 082715-1, Exp. 06/24/2018; 061715-1, Exp. 6/6/2018; 072516-2, Exp. 07/04/2019; b) 082715-1, Exp. 06/24/2018; 061715-1, Exp. 6/6/2018; 072516-2, Exp. 07/04/2019; c) 061715-1, Exp. 6/6/2018; 072516-2, Exp. 07/04/2019; 082715-1, Exp. 06/24/2018; d) 072516-1, Exp. 07/04/2019; 082715-1, Exp. 06/24/2018;"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-084-2014", "product_description": "EDTA 3% 30ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1 unit", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Ongoing", "city": "Allendale", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89289", "recalling_firm": "Revive Personal Products Company", "address_1": "2 Myrtle Ave", "address_2": "N/A", "postal_code": "07401-1515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0364-2022", "product_description": "The Natural Dentist Healthy Balance Peppermint Sage, Menthol 0.12%, 16.9 FL OZ (500 mL) bottles, Manufactured for Revive Personal Products Company, Madison, NJ 07940, UPC 7 14132 00071 4", "product_quantity": "258 bottles", "reason_for_recall": "Labeling; Label mix-up and Wrong Bar Code; back label incorrectly states active ingredient as Menthol with UPC  7 14132 00071 4 instead of Peppermint Oil and Sage Oil with UPC 7 14132 00073 8", "recall_initiation_date": "20210928", "center_classification_date": "20220110", "report_date": "20220119", "code_info": "Lot 2091A,  exp 7/2023"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0982-2019", "product_description": "Dr. King's Natural Medicine Leg Cramp & Spasm Relief Homeopathic, 2 fl oz (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955543527, NDC 57955-6035-2", "product_quantity": "9405 bags", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 102816D Exp. 10/19; 050516F Exp. 05/19; 101416A Exp. 10/19; 123115D Exp. 12/18; 041518J Exp. 04/20"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0172-2022", "product_description": "TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.5MG/ML INJ #2 IN SESAME OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "9 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1004132021:95 BUD: 10/10/2021; T1006162021:63 BUD: 12/13/2021; T1004282021:19 BUD: 10/25/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065261"], "brand_name": ["CEFPROZIL"], "generic_name": ["CEFPROZIL"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-401", "68180-402"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFPROZIL"], "rxcui": ["309080", "309081"], "spl_id": ["45d1a412-407b-48d4-be64-b9c7ec3c5205"], "spl_set_id": ["3ec55c0a-1456-412e-972f-352b3135c8f2"], "package_ndc": ["68180-401-03", "68180-401-01", "68180-401-02", "68180-402-01", "68180-402-03", "68180-402-02"], "is_original_packager": [true], "upc": ["0368180401032", "0368180402039"], "nui": ["N0000175488", "M0003827"], "pharm_class_epc": ["Cephalosporin Antibacterial [EPC]"], "pharm_class_cs": ["Cephalosporins [CS]"], "unii": ["4W0459ZA4V"]}, "product_type": "Drugs", "event_id": "87602", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0332-2021", "product_description": "Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL (when mixed) bottles (NDC 68180-402-02); and c) 100 mL (when mixed) bottles (NDC 68180-402-03); Rx only, Manufactured for: Lupin Pharmaceutical, Inc., Baltimore, MD  21202; Manufactured by: Lupin Limited, Mandideep 462 046, India.", "product_quantity": "a) 6,816 bottles; b) 3,960 bottles and c) 7,038 bottles", "reason_for_recall": "Superpotent Drug", "recall_initiation_date": "20210326", "center_classification_date": "20210412", "termination_date": "20211216", "report_date": "20210421", "code_info": "Lot Numbers: a) F801122, exp. date June 2021; b) F801123, exp. date June 2021; c) F801124, exp. date June 2021"}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA091657"], "brand_name": ["TRANEXAMIC ACID"], "generic_name": ["TRANEXAMIC ACID"], "manufacturer_name": ["Mylan Institutional LLC"], "product_ndc": ["67457-197"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TRANEXAMIC ACID"], "rxcui": ["238720"], "spl_id": ["8b527f21-61b4-4707-8ea5-629f47f707e2"], "spl_set_id": ["6f033f1e-8c78-4c87-b870-6493944315ff"], "package_ndc": ["67457-197-00", "67457-197-10"], "is_original_packager": [true], "nui": ["N0000175634", "N0000175632"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "unii": ["6T84R30KC1"]}, "product_type": "Drugs", "event_id": "86247", "recalling_firm": "Mylan Institutional LLC", "address_1": "4901 Hiawatha Dr", "address_2": "N/A", "postal_code": "61103-1287", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1576-2020", "product_description": "Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00); 10 x 10 mL Single-Dose Vials per carton (NDC 67457-197-10), Rx only, Manufactured by: Mylan Institutional, Galway, Ireland; Manufactured for: Mylan Institutional LLC, Rockford, IL  61103.", "product_quantity": "1407 cartons", "reason_for_recall": "Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.", "recall_initiation_date": "20200817", "center_classification_date": "20200911", "termination_date": "20221228", "report_date": "20200909", "code_info": "Lot #: 191207, 191221, 191223,  Exp. 11/2021; 200120 Exp. 12/2021"}, {"status": "Ongoing", "city": "Rafelbunol", "state": "N/A", "country": "Spain", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73574", "recalling_firm": "Sesderma, SL", "address_1": "Calle Massamagrell 3-5", "address_2": "Poligono Industrial Rafelbunol", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed to following states: FL, PR, CO, GA.", "recall_number": "D-0844-2016", "product_description": "Repaskin 50 (octocrylene 7%, titanium dioxide 2%) Body Lotion Sunscreen gel cream, Broad Spectrum SPF 50, 6.8 fl oz (200 mL) tube, over the counter,  Manufactured by Sesderma S.L., Valencia, Spain, NDC 63181-0013-1, UPC 8 429979 415707", "product_quantity": "15 bottles", "reason_for_recall": "cGMP Deviations; product does not comply with cGMP requirements", "recall_initiation_date": "20151015", "center_classification_date": "20160510", "report_date": "20160518", "code_info": "Lot code 41464901, exp 05/17"}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97360", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide Within the U.S.", "recall_number": "D-0573-2025", "product_description": "RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA, Cambridge, MA 02142, NDC: 00944-2843-01", "product_quantity": "3 units", "reason_for_recall": "CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.", "recall_initiation_date": "20250730", "center_classification_date": "20250807", "report_date": "20250813", "code_info": "Lot: TRB23802AC, Expires: 03/18/2026; TRA22804AA, Expires: 10/18/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-846-2015", "product_description": "Podophyllum Resin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Norwalk", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91719", "recalling_firm": "Ecometics, Inc.", "address_1": "19 Concord St", "address_2": "", "postal_code": "06854-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0451-2023", "product_description": "Activator Concentrate (sodium fluoride 0.96% in Activator) 1 fl. Oz, liquid oral rinse plastic bottles, Manufactured for: All USA Direct LLC, Broadview, IL 60155", "product_quantity": "34,320 bottles", "reason_for_recall": "CGMP DEVIATIONS", "recall_initiation_date": "20230224", "center_classification_date": "20230308", "termination_date": "20230621", "report_date": "20230315", "code_info": "Lot #: 2E055A, Exp. Date Feb-2025", "more_code_info": ""}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65154", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.", "recall_number": "D-434-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP) , 75 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1322-01", "product_quantity": "19,787 Bottles", "reason_for_recall": "cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.", "recall_initiation_date": "20130401", "center_classification_date": "20130521", "termination_date": "20140508", "report_date": "20130529", "code_info": "Lot #: 1098752, Exp. Mar-13; 1099890, Exp Apr-13."}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0688-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2%/Dextrose 10% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0416-1.", "product_quantity": "139 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-897800, Exp 05/12/2023; 37-897895, Exp 05/13/2023"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1600-2019", "product_description": "Herpes-G Capsules, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0509-2018", "product_description": "Liothyronine Sodium USP  for prescription compounding ,1g, RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327, NDC 58597-8021-2.", "product_quantity": "73 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: 090517A-1, Exp. 09/13/2018"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; SENNOSIDES Tablet, 8.6 mg may be potentially mislabeled as    SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg, NDC 00414200007, Pedigree: AD37063_7, EXP: 5/13/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "SENNOSIDES, Tablet, 8.6 mg has the following code    Pedigree: AD37063_17, EXP: 5/13/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SENNOSIDES Tablet, 8.6 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 60258095001", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-656-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Cheshire", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA125166"], "brand_name": ["SOLIRIS"], "generic_name": ["ECULIZUMAB"], "manufacturer_name": ["Alexion Pharmaceuticals Inc."], "product_ndc": ["25682-001"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ECULIZUMAB"], "rxcui": ["700384", "700387"], "spl_id": ["25021c88-95e1-42f0-b895-921526b90642"], "spl_set_id": ["ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722"], "package_ndc": ["25682-001-01"], "is_original_packager": [true], "nui": ["N0000175575", "N0000175974"], "pharm_class_epc": ["Complement Inhibitor [EPC]"], "pharm_class_moa": ["Complement Inhibitors [MoA]"], "unii": ["A3ULP0F556"], "upc": ["325682001016"]}, "product_type": "Drugs", "event_id": "68401", "recalling_firm": "Alexion Pharmaceuticals, Inc.", "address_1": "352 Knotter Dr", "address_2": "N/A", "postal_code": "06410-1138", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1512-2014", "product_description": "Soliris (eculizumab), 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT 06410, NDC 25682-001-01, UPC 3 25682-001-01 6.", "product_quantity": "96,506 vials", "reason_for_recall": "Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.", "recall_initiation_date": "20140602", "center_classification_date": "20140805", "termination_date": "20150529", "report_date": "20140813", "code_info": "Lots: 10002-1, 00006-1, Exp 08/14;  10003A, Exp 11/14; 10004A, Exp 02/15; 10005A, 10005AR, 10007A, 10006A, Exp 07/15; and 10008A, Exp 08/15"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78320", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0066-2018", "product_description": "PHENYLephrine HCl 100 mcg per mL In 0.9% Sodium Chloride 10 mL Fill Volume in a Single Dose Syringe (1,000 mcg / 10 ml Total Dose), Rx Only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR, NDC 70004-0810-12", "product_quantity": "1221 syringes", "reason_for_recall": "Lack Of Assurance Of Sterility.", "recall_initiation_date": "20171019", "center_classification_date": "20171102", "termination_date": "20190501", "report_date": "20171108", "code_info": "Lot: 20170920@53 BUD: 12/19/2017"}, {"status": "Terminated", "city": "Rosenberg", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93986", "recalling_firm": "Seatex LLC", "address_1": "445 Highway 36 N", "address_2": "", "postal_code": "77471-8756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US and Puerto Rico", "recall_number": "D-0359-2024", "product_description": "7 Eleven Hand Sanitizer Gel, Ethanol 70% v/v Antiseptic, Mountain Spring Scent, 1250 mL cases, Magnus 16005 Gateway Drive, Ste 300, Frisco, TX 75033", "product_quantity": "1,282 cases", "reason_for_recall": "CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.", "recall_initiation_date": "20240219", "center_classification_date": "20240229", "termination_date": "20250815", "report_date": "20240306", "code_info": "Lot #s: 266029, Exp. 03/27/2024; 255917, Exp. 06/23/2024; 261521, Exp. 06/27/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021254"], "brand_name": ["ADVAIR HFA"], "generic_name": ["FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0715", "0173-0716", "0173-0717"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FLUTICASONE PROPIONATE", "SALMETEROL XINAFOATE"], "rxcui": ["896231", "896235", "896236", "896237", "896239", "896243", "896244", "896245", "896267", "896271", "896272", "896273"], "spl_id": ["6fba7158-0e93-43af-b18b-89ed7d4dcc8d"], "spl_set_id": ["dfaca6f9-3277-47b2-319d-1377917cb54c"], "package_ndc": ["0173-0715-20", "0173-0715-22", "0173-0716-20", "0173-0716-22", "0173-0717-20", "0173-0717-22"], "is_original_packager": [true], "unii": ["6EW8Q962A5", "O2GMZ0LF5W"]}, "product_type": "Drugs", "event_id": "63707", "recalling_firm": "GlaxoSmithKline, LLC.", "address_1": "1011 North Arendell Ave", "address_2": "N/A", "postal_code": "27597-1217", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-065-2013", "product_description": "Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg  60 Actuations INST, NDC 0173-0715-22, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709.", "product_quantity": "18,676 Aerosol Units", "reason_for_recall": "Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.", "recall_initiation_date": "20121024", "center_classification_date": "20121123", "termination_date": "20140911", "report_date": "20121205", "code_info": "1ZP3065, Exp. Oct-12, 1ZP5453, Exp. Dec-12, 1ZP3315, Exp. May-13, 2ZP9974, Exp. Sep-13."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0915-2019", "product_description": "NET Remedies #2 Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia", "product_quantity": "2500 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: AUS-011916B Exp. 01/19; AUS-011117B Exp. 01/20; AUS-030816B Exp. 03/19; AUS-050516B Exp. 05/19; AUS-081516G Exp. 08/19; AUS-091515B Exp. 09/18"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:N0407992, N0387607, N0394440, N0402003, N0409979, N0399632", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BACLOFEN/HYDROMORPHONE, P.F. 2000MCG/2.9MG/ML INTRATHECAL 20 ML; BACLOFEN/HYDROMORPHONE, P.F. 2000MCG/6MG/ML INTRATHECAL 40 ML; BACLOFEN/HYDROMORPHONE, P.F. 500MCG/50MG/ML INTRATHECAL 40 ML (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1461-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Oklahoma City", "address_1": "755 Research Pkwy Ste 150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "unknown", "code_info": "all lot codes", "center_classification_date": "20140729", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Dermamedics Baby's Relief Calm and Repair Cream in 2 oz. containers with a SKU number of DM1016 and 0.25 containers with a SKU number of PS 1016; and Therametics Baby's Relief Calm and Repair Cream in 2 oz. containers with a SKU number of BR008.", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Dermamedics, L.L.C.", "recall_number": "D-1489-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67247", "termination_date": "20170314", "more_code_info": "", "recall_initiation_date": "20140110", "postal_code": "73104-3621", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Roswell", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "77333", "recalling_firm": "DYNAMIC TECHNICAL FORMULATIONS", "address_1": "660 Hembree Pkwy Ste 115", "address_2": "N/A", "postal_code": "30076-4974", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. nationwide", "recall_number": "D-1087-2017", "product_description": "Biotech Underground Tri-Ton Hardcore Formula capsules, 90-count bottle, Distributed by: Dynamic Technical Formulations 12850 Hwy 9 Suite 600-441 Alpharetta, GA 30004", "product_quantity": "728 bottles", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplement: Product was tested by FDA and found to contain andarine and ostarine.", "recall_initiation_date": "20170519", "center_classification_date": "20170814", "termination_date": "20200507", "report_date": "20170823", "code_info": "All lots"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-578-2015", "product_description": "Chlorobutanol Hemihydrate pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "6900 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "6726  Cases", "code_info": "Product Code: 6704; Lots: 58121, EXP 09/19/2017; 58771, EXP 10/09/2017; 59394, EXP 11/15/2017; 59400, EXP 12/15/2017; 60389, EXP 01/08/2018; 60453, 61087, EXP 01/22/2018; 61121, EXP 03/05/2018; 61579, EXP 04/17/2018.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Q.Care Petite Size Oral Cleansing & Suctioning System. Contains 1 Covered Yankauer, Suction Handle and Y-Connector, 2 Petit Size Suction Toothbrush packages with Antiseptic Oral Rinse, 4 Petit Size Untreated Suction Oral Swab packages with Antiseptic Oral Rinse, 2 8 French Oropharyngeal Suction Catheter packages. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6704 UPC 6 18029 84123 0", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0393-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091269"], "brand_name": ["LANSOPRAZOLE"], "generic_name": ["LANSOPRAZOLE"], "manufacturer_name": ["Dr.Reddy's Laboratories Ltd."], "product_ndc": ["55111-398", "55111-399"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LANSOPRAZOLE"], "rxcui": ["311277", "596843"], "spl_id": ["c8eb1d41-1fd2-7c06-486c-e6abf08faa6d"], "spl_set_id": ["82174fcc-1b0f-2068-7fc4-db335b43b5e2"], "package_ndc": ["55111-398-30", "55111-398-60", "55111-398-90", "55111-398-01", "55111-398-05", "55111-398-79", "55111-399-30", "55111-399-60", "55111-399-90", "55111-399-01", "55111-399-05", "55111-399-79"], "is_original_packager": [true], "nui": ["N0000175525", "N0000000147", "N0000009724"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]"], "pharm_class_pe": ["Inhibition Gastric Acid Secretion [PE]"], "unii": ["0K5C5T2QPG"]}, "product_type": "Drugs", "event_id": "89871", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0738-2022", "product_description": "Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India, NDC 55111-399-90.", "product_quantity": "7,703 bottles", "reason_for_recall": "Failed Dissolution Specifications; during long term stability testing.", "recall_initiation_date": "20220323", "center_classification_date": "20220331", "termination_date": "20240202", "report_date": "20220406", "code_info": "Lot# C2102911, Exp. 12/2023"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA016964"], "brand_name": ["MARCAINE"], "generic_name": ["BUPIVACAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-0525", "0409-1559", "0409-1560", "0409-1582", "0409-1587", "0409-1610", "0409-1746", "0409-1749", "0409-1752", "0409-1755", "0409-2510", "0409-7535", "0409-1250", "0409-5010", "0409-1530", "0409-7510", "0409-2253"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["PERINEURAL"], "substance_name": ["BUPIVACAINE HYDROCHLORIDE"], "rxcui": ["1012377", "1012381", "1012384", "1012388", "1012396", "1012400", "1012404", "1012406", "1672917", "1672919", "1673242", "1673243", "1724786", "1724787", "1724794", "1724796", "1724880", "1724884", "1725044", "1725046", "1725078", "1725079", "1725082", "1725083", "1867594", "1867596", "1867612", "1867614"], "spl_id": ["b00b78c3-c70d-49b9-a381-6a1496f74153"], "spl_set_id": ["67578b56-7540-487e-1fba-481255620e78"], "package_ndc": ["0409-1559-18", "0409-1559-10", "0409-1559-19", "0409-1559-30", "0409-1560-18", "0409-1560-10", "0409-1560-19", "0409-1560-29", "0409-1582-18", "0409-1582-10", "0409-1582-19", "0409-1582-29", "0409-1587-50", "0409-1610-50", "0409-1746-70", "0409-1746-10", "0409-1746-71", "0409-1746-30", "0409-1749-70", "0409-1749-10", "0409-1749-71", "0409-1749-29", "0409-1752-50", "0409-1755-50", "0409-2510-01", "0409-2510-25", "0409-7535-01", "0409-7535-25", "0409-1250-01", "0409-1250-25", "0409-5010-01", "0409-5010-25", "0409-1530-01", "0409-1530-25", "0409-0525-01", "0409-0525-25", "0409-7510-01", "0409-7510-25", "0409-2253-01", "0409-2253-25"], "is_original_packager": [true], "unii": ["7TQO7W3VT8", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "75156", "recalling_firm": "Hospira Inc., A Pfizer Company", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0096-2017", "product_description": "Marcaine 0.25% (bupivacaine HCl) injection, USP, 125 mg/50 mL (2.5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1587-50.", "product_quantity": "15 vials", "reason_for_recall": "Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.", "recall_initiation_date": "20160916", "center_classification_date": "20161013", "termination_date": "20190731", "report_date": "20161019", "code_info": "Lot #: 60295DD,  Ep 1DEC2017"}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1542-2019", "product_description": "CHARMS BLOW POP CHERRY SCENTED ANTIBACTERIAL HAND GEL (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed by: JFL Enterprises, Inc. Cleveland, Ohio 44102.", "product_quantity": "18036", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181025, Exp 10/24/2020; 20181026, Exp 10/25/2020"}, {"status": "Terminated", "city": "Berwyn", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA209080"], "brand_name": ["TIGLUTIK"], "generic_name": ["RILUZOLE"], "manufacturer_name": ["EDW PHARMA, INC"], "product_ndc": ["70726-0303"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RILUZOLE"], "rxcui": ["2058147", "2059266"], "spl_id": ["2012817c-c76a-40d4-a2c8-cdb211737f3d"], "spl_set_id": ["75d68f19-4208-109e-e053-2991aa0ac857"], "package_ndc": ["70726-0303-2", "70726-0303-1"], "is_original_packager": [true], "nui": ["N0000175740", "M0483511"], "pharm_class_epc": ["Benzothiazole [EPC]"], "pharm_class_cs": ["Benzothiazoles [CS]"], "unii": ["7LJ087RS6F"]}, "product_type": "Drugs", "event_id": "93278", "recalling_firm": "ITF PHARMA INC", "address_1": "850 Cassatt Rd", "address_2": "N/A", "postal_code": "19312-2701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to one distributor in TN who may have further distributed.", "recall_number": "D-0115-2024", "product_description": "Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL), 600 mL (two bottles/300 mL each), RX only, Manufactured for ITF Pharma, Inc., Berwyn, PA 19312 USA NDC:70726-0303-1 (carton) and 70726-0303-2 (bottle)", "product_quantity": "1,792 bottles", "reason_for_recall": "Failed Viscosity Specifications: Out-of-specification test results for viscosity", "recall_initiation_date": "20231020", "center_classification_date": "20231121", "termination_date": "20250128", "report_date": "20231129", "code_info": "LOT# 2231901, Exp. 11/30/2025; 2307901, Exp. 03/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Cresson", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93199", "recalling_firm": "Integrity Bio-Chemicals LLC", "address_1": "1100 N Cresson Hwy", "address_2": "N/A", "postal_code": "76035-4121", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed to one distributor in OK with possibility of further distribution", "recall_number": "D-0110-2024", "product_description": "Integrity Biochem HSC70-LV, Alcohol Antiseptic 70%, Hand Sanitizer, Lavender Scented Topical Gel 208.19L (55 gallons) drum, Integrity Biochem, 1100 North Cresson Hwy, Cresson, TX 76035. Made in the USA,  NDC: 77512-047-03", "product_quantity": "1 55-gallon drum", "reason_for_recall": "CGMP Deviation: Third party test results showing a presence of acetal and acetaldehyde at levels above USP specified amounts.", "recall_initiation_date": "20231018", "center_classification_date": "20231120", "termination_date": "20250321", "report_date": "20231129", "code_info": "Lot #: 2133608, No exp Date.  Manufacturing Date:  11/23/21", "more_code_info": ""}, {"status": "Completed", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA076517"], "brand_name": ["CARBOPLATIN"], "generic_name": ["CARBOPLATIN"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["61703-339"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CARBOPLATIN"], "rxcui": ["597195"], "spl_id": ["0ddf4411-7138-412a-908a-fadf22bdfb79"], "spl_set_id": ["c3ae9880-44bb-4f4e-93d8-8a5e21708a30"], "package_ndc": ["61703-339-18", "61703-339-22", "61703-339-50", "61703-339-56", "61703-360-50"], "is_original_packager": [true], "nui": ["N0000175413", "N0000175073"], "pharm_class_epc": ["Platinum-based Drug [EPC]"], "unii": ["BG3F62OND5"]}, "product_type": "Drugs", "event_id": "63548", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-154-2013", "product_description": "Carboplatin Injection, 450 mg/45 mL (10 mg/mL), 45 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use, NDC 61703-339-50 (Hospira label) and NDC 61703-360-50 (Novaplus label), Hospira, Inc., Lake Forest, IL 60045, Product of Australia.", "product_quantity": "31,326 vials", "reason_for_recall": "Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.", "recall_initiation_date": "20121108", "center_classification_date": "20130206", "termination_date": "20170320", "report_date": "20130213", "code_info": "lots Z011711AA (Hospira label) and Z011711AB (Novaplus label), Exp. 08/2013", "more_code_info": ""}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076899"], "brand_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "generic_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-271", "65162-272"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SULFAMETHOXAZOLE", "TRIMETHOPRIM"], "rxcui": ["198334", "198335"], "spl_id": ["6cbe0ea0-5ed0-4941-ad3c-4396a56fdfc6"], "spl_set_id": ["f0e73842-6002-43c2-97fc-0cadc1bf6346"], "package_ndc": ["65162-271-05", "65162-271-10", "65162-271-50", "65162-271-11", "65162-272-01", "65162-272-24", "65162-272-10", "65162-272-25", "65162-272-50"], "is_original_packager": [true], "upc": ["0365162271102", "0365162272109"], "nui": ["N0000175504", "M0020790", "N0000185504", "N0000175489", "N0000000191", "N0000187062", "N0000187061"], "pharm_class_epc": ["Sulfonamide Antimicrobial [EPC]", "Dihydrofolate Reductase Inhibitor Antibacterial [EPC]"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_moa": ["Cytochrome P450 2C9 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "unii": ["JE42381TNV", "AN164J8Y0X"]}, "product_type": "Drugs", "event_id": "97438", "recalling_firm": "Amneal Pharmaceuticals, LLC", "address_1": "400 Crossing Blvd Fl 3", "address_2": "N/A", "postal_code": "08807-2863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0615-2025", "product_description": "Sulfamethoxazole and Trimethoprim Tablets, USP 800mg/160mg, Double Strength, Rx Only, Packaged as a) 100-count bottle, NDC 65162-272-10; b) 500-count bottle, NDC  65162-272-50; Manufactured by: Amneal Pharmaceuticals, Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad, 382213, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.", "product_quantity": "60,072 100-count, 73,054 500-count bottles", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was   detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250818", "center_classification_date": "20250904", "report_date": "20250910", "code_info": "Lot a) AM240173, Exp Date 01/31/2027, AM240680, Exp Date 05/31/2027, AM 240921, Exp Date 06/30/2027, AM241191, Exp Date 08/31/2027.  Lot b) AM240176, AM240177, Exp Date 01/31/2027, AM240301, AM240300, Exp Date 02/28/2027, AM240676, AM240677, Exp Date 04/30/2027, AM240678, AM240679, Exp Date 05/30/2027. AM240922, AM240923, AM240924, AM240925, Exp Date 6/30/27, AM241086, Exp Date 7/31/27, AM241087, AM241088, Exp Date 8/31/27."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-787-2015", "product_description": "Methscopolamine Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "45 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 112 mcg may have potentially been mislabeled as one of the following drugs:  ZINC SULFATE, Capsule, 220 mg (50 mg Elem Zn), NDC 00904533260, Pedigree: AD57624_1, EXP: 5/9/2014;  hydrALAZINE HCl, Tablet, 50 mg, NDC 50111032801, Pedigree: AD52778_28, EXP: 5/20/2014;  CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: W003828, EXP: 6/", "address_2": "", "product_quantity": "499 Tablets", "code_info": "LEVOTHYROXINE SODIUM, Tablet, 112 mcg has the following codes:   Pedigree: AD60211_1, EXP: 5/21/2014;  Pedigree: AD52778_37, EXP: 5/20/2014;  Pedigree: W003847, EXP: 6/27/2014;  Pedigree: AD30197_13, EXP: 5/9/2014;  Pedigree: AD49423_7, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE SODIUM, Tablet, 112 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378181101.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-898-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "60 mL total", "code_info": "Lot # 01-20-2017@17, Exp 4/20/2017; 01-23-2017@48, Exp 4/23/2017; 01-27-2017@17, Exp 4/27/2017; 01-31-2017@42, Exp 5/1/2017; 02-01-2017@35, Exp 5/2/2017; t02-07-2017@67, Exp 5/9/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "ATROPINE SULFATE 0.01% OPHTH, Ophthalmic, 0.01%, Rx only, 15 mL Glass /Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0711-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62772", "recalling_firm": "Prometheus Laboratories Inc.", "address_1": "9410 Carroll Park Dr", "address_2": "N/A", "postal_code": "92121-5201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-1659-2012", "product_description": "Mercaptopurine Tablets, USP, 50 mg, packaged in a) 60-count tablets per bottle (NDC 49884-922-02) and b) 250-count tablets per bottle (NDC 49884-922-04), Rx only, Distributed by: Par Pharmaceutical Companies, Inc., Spring Valley, NY  10977.", "product_quantity": "a) 25,516 bottles; b) 2,569 bottles", "reason_for_recall": "Failed USP Dissolution Test Requirements: The recalled lots do not meet the specification for dissolution.", "recall_initiation_date": "20120629", "center_classification_date": "20120822", "termination_date": "20130327", "report_date": "20120829", "code_info": "Lot #s: a) 11A003, 11A004, 11A005, Exp 01/13; 11L071, 11L072, Exp 10/13; b) 11B009, Exp 01/13; 11L073, Exp 10/13"}, {"country": "United States", "city": "Hobart", "address_1": "3401 W 37th Ave", "reason_for_recall": "Superpotent Drug: Product may not be uniformly blended resulting in non-uniform distribution of the active ingredient menthol.", "address_2": "", "product_quantity": "a) 630 2 oz. Tubes, b) 859 5 oz. Jars", "code_info": "Lot # 6086221, Exp 10/16", "center_classification_date": "20150625", "distribution_pattern": "Nationwide and Puerto Rico", "state": "IN", "product_description": "Dr Blue Pain Relieving Gel, (4.6% menthol), For temporary relief of minor aches and pains of muscles and joints, a) 2 oz. Tube, NDC 10578-035-05, b) 5 oz. Jar, NDC 10578-035-04, Manufactured by Indiana Botanic Gardens, Hobart, IN 46342", "report_date": "20150701", "classification": "Class III", "openfda": {}, "recalling_firm": "Indiana Botanic Gardens, Inc", "recall_number": "D-1149-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "71426", "termination_date": "20160321", "more_code_info": "", "recall_initiation_date": "20150604", "postal_code": "46342-1751", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-588-2015", "product_description": "Ciprofloxacin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "3100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA018016"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0043", "0338-0049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807627", "1807630", "1807631", "1807632", "1807633", "1807634", "1807639"], "spl_id": ["6ab23768-efd2-4ff1-b336-0dda08dc56e1"], "spl_set_id": ["f55bd888-5e01-474d-871b-24654c070178"], "package_ndc": ["0338-0049-01", "0338-0049-02", "0338-0049-03", "0338-0049-04", "0338-0049-10", "0338-0049-41", "0338-0049-11", "0338-0049-31", "0338-0049-48", "0338-0049-18", "0338-0049-38", "0338-0043-03", "0338-0043-04"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "68728", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, Singapore, and Hong Kong", "recall_number": "D-1591-2014", "product_description": "0.9% Sodium Chloride Injection USP, packaged in a) 50 mL VIAFLEX Container bags, NDC 0338-0049-41, Product Code 2B1306; and b) 100 mL VIAFLEX Container bags, NDC 0338-0049-18, Product Code 2B1302, Rx only, Baxter Healthcare Corporation, Deerfield, IL  60015 USA.", "product_quantity": "a) 217,536 bags; b) 161,760 bags", "reason_for_recall": "Presence of Particulate Matter: particulate matter identified as fibers and/or plastics.", "recall_initiation_date": "20140711", "center_classification_date": "20140918", "termination_date": "20160921", "report_date": "20140924", "code_info": "Lot #: a) P309187, Exp 10/14; b) P298190, Exp 08/14", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA204550"], "brand_name": ["AMIODARONE HYDROCHLORIDE"], "generic_name": ["AMIODARONE HYDROCHLORIDE"], "manufacturer_name": ["AuroMedics Pharma LLC"], "product_ndc": ["55150-180", "55150-181", "55150-182"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["AMIODARONE HYDROCHLORIDE"], "rxcui": ["833532", "1663224", "1663244"], "spl_id": ["c2e4f552-4ed1-4c8c-b865-39596b79b1ad"], "spl_set_id": ["6cd870d7-6381-421a-89bc-bce5c9518219"], "package_ndc": ["55150-180-03", "55150-181-09", "55150-182-18"], "is_original_packager": [true], "upc": ["0355150180035", "0355150182183", "0355150181094"], "unii": ["976728SY6Z"]}, "product_type": "Drugs", "event_id": "84240", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-0521-2020", "product_description": "Amiodarone Hydrochloride Injection, USP, 450 mg per 9 mL (50 mg / mL), 9 mL Single Dose Vial, Rx only, Distributed by AuroMedics Pharma LLC E. Windsor, NJ. 08520, Made in India. NDC 55150-181-09", "product_quantity": "29,830 vials", "reason_for_recall": "Crystallization: Presence of visible particulate matter.", "recall_initiation_date": "20191111", "center_classification_date": "20191122", "termination_date": "20210401", "report_date": "20191204", "code_info": "Lot# CAH180001, exp. date Jan 2020; CAH180003, exp. date Feb 2020; CAH180011, CAH180012, exp. date Jun 2020", "more_code_info": ""}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "7 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Vitamin B-Complex 100 Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0468-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203602"], "brand_name": ["MORPHINE SULFATE"], "generic_name": ["MORPHINE SULFATE"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-540", "43386-541", "43386-542", "43386-543", "43386-544"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MORPHINE SULFATE"], "rxcui": ["891874", "891881", "891888", "891893", "892646"], "spl_id": ["d4efe614-fe99-4cc7-b3ba-87c4e010efbd"], "spl_set_id": ["d360a33f-6323-4b10-9e81-07e2813c2dbd"], "package_ndc": ["43386-540-01", "43386-540-05", "43386-541-01", "43386-541-05", "43386-542-01", "43386-542-05", "43386-543-01", "43386-543-05", "43386-544-01", "43386-544-05"], "is_original_packager": [true], "upc": ["0343386542017", "0343386543014", "0343386540013", "0343386541010"], "unii": ["X3P646A2J0"]}, "product_type": "Drugs", "event_id": "82581", "recalling_firm": "LUPIN SOMERSET", "address_1": "400 Campus Dr", "address_2": "N/A", "postal_code": "08873-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was shipped to 5 wholesalers and one Supermarket Chain who may have further distributed the product throughout the United States.", "recall_number": "D-1243-2019", "product_description": "Morphine Sulfate Extended-Release Tablets, 15 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-540-01", "product_quantity": "17,328 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20190410", "center_classification_date": "20190425", "termination_date": "20221014", "report_date": "20190501", "code_info": "Lot#: S700220, Exp. Apr 30 2019; S700604, Exp. July 31 2019; S800326, Exp. Mar 31 2020"}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA017464"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-1800"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807630", "1807631", "1807632"], "spl_id": ["7d4ee37f-5016-422c-9f66-e675ae22c46a"], "spl_set_id": ["cc14fafd-3dcd-4fc8-bdbd-6f355c375768"], "package_ndc": ["0264-1800-36", "0264-1800-31", "0264-1800-32"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "66913", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 McGaw Ave", "address_2": "", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico and Spain", "recall_number": "D-1265-2014", "product_description": "0.9 % Sodium Chloride Injection USP in PAB 50 mL partial fill in 100 mL PAB Container, Catalog No. S8004-5384, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-1800-31", "product_quantity": "53,592 units", "reason_for_recall": "Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.", "recall_initiation_date": "20131121", "center_classification_date": "20140425", "termination_date": "20141204", "report_date": "20140507", "code_info": "Lot# J2P912, Exp 02/14", "more_code_info": ""}, {"status": "Terminated", "city": "Middletown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80053", "recalling_firm": "RIJ Pharmaceutical LLC", "address_1": "40 Commercial Ave", "address_2": "N/A", "postal_code": "10941-1444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0844-2018", "product_description": "RPC Senna Syrup (Sennosides 8.8mg), packaged in 8 fl oz (237 mL) bottles, RIJ Pharmaceuticals Corporation   40 Commercial Avenue, Middletown, NJ 10941, NDC 5380755608, UPC 353807556080", "product_quantity": "1505 bottles", "reason_for_recall": "CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.", "recall_initiation_date": "20180507", "center_classification_date": "20180608", "termination_date": "20230407", "report_date": "20180620", "code_info": "Lot #: 47070081, Exp 09/18"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: VALSARTAN, Tablet, 40 mg may have potentially been mislabeled as one of the following drugs:  VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree: AD52372_4, EXP: 5/17/2014;  ZINC SULFATE, Capsule, 50 mg, NDC 00904533260, Pedigree: AD30994_8, EXP: 5/9/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "VALSARTAN, Tablet, 40 mg has the following codes:   Pedigree: AD52372_1, EXP: 5/17/2014;  Pedigree: AD32579_1, EXP: 5/9/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VALSARTAN, Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078042315.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-819-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "7000 mL  in Vials", "code_info": "Lot #: 151221-56, BUD: 06/18/16;  Lot #: 160203-23, BUD: 08/01/16;  Lot #: 160218-45, BUD: 08/16/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "HYDROXY B12 1000MCG/ML   W/PRES (BENZALKONIUM 0.01%), 10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1192-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202223"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-570", "65862-571", "65862-572", "65862-573"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["7b329c09-5c17-4117-9cef-a383ecec90d9"], "spl_set_id": ["a81a72dd-e828-4208-af9b-bb9ac4938537"], "package_ndc": ["65862-570-30", "65862-570-99", "65862-570-10", "65862-571-90", "65862-571-99", "65862-571-10", "65862-572-90", "65862-572-99", "65862-572-10", "65862-573-90", "65862-573-05"], "is_original_packager": [true], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "82114", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to major distribution chains throughout the United States.", "recall_number": "D-1037-2019", "product_description": "Valsartan Tablets USP 40 mg, 30 count bottles, Rx only,  Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-570-30", "product_quantity": "N/A", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181231", "center_classification_date": "20190321", "report_date": "20190327", "code_info": "Lot Numbers:  470180008A, exp. date Feb 2020; 470180014A, 470180016A, exp. date Mar 2020; 470180032A, exp. date May 2020"}, {"status": "Terminated", "city": "Earth City", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67978", "recalling_firm": "Legacy Pharmaceutical Packaging", "address_1": "13333 Lakefront Dr", "address_2": "N/A", "postal_code": "63045-1514", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "IN", "recall_number": "D-1363-2014", "product_description": "Pantoprazole Sodium, Delayed-release tablets, USP, 40 mg tablets, 100 (10x10) unit dose packages, Manufactured by Dr. Reddy's Laboratories Limited, India and Distributed by Major Pharmaceuticals, Livonia, MI --- NDC 0904-6235-61", "product_quantity": "unknown", "reason_for_recall": "Correct Labeled Product Miscart/Mispack: some cartons labeled as Pantoprazole Sodium Delayed-Release may contain correctly labeled blister cards of Lorazepam tablets", "recall_initiation_date": "20140409", "center_classification_date": "20140610", "termination_date": "20170106", "report_date": "20140618", "code_info": "No lot or expiration date is displayed on this carton."}]